Artificial Intelligence-assisted System in Colonoscopy
To Evaluate the Effectiveness and Safety of an Artificial Intelligence-assisted System in Colonoscopy in a Real-world Obsevational Multicenter Study
1 other identifier
observational
7,500
1 country
1
Brief Summary
In recent years, computer-aided diagnosis system based on artificial intelligence (AI) has been used in colorectal polyp detection. In recent years, computer-aided diagnosis system based on artificial intelligence (AI) has been used in colorectal polyp detection. However, whether AI-assisted can improve the adenoma-detection rate (ADR) is inconclusive. This study aims to evaluate the real-world performance of an AI system that combines polyp detection with colonoscopy quality control. This study aims to explore the clinical application value of AI-based polyp detection and quality control function by comparing the data of polyp detection rate and adenoma detection rate in multiple centers with and without AI-assisted colonoscopy in a multicenter, prospective real world study. However, whether AI-assisted can improve the adenoma-detection rate (ADR) is inconclusive. This study aims to evaluate the real-world performance of an AI system that combines polyp detection with colonoscopy quality control. This study aims to explore the clinical application value of AI-based polyp detection and quality control function by comparing the data of polyp detection rate and adenoma detection rate in multiple centers with and without AI-assisted colonoscopy in a multicenter, prospective real world study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2024
CompletedFirst Posted
Study publicly available on registry
May 9, 2024
CompletedStudy Start
First participant enrolled
May 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedApril 13, 2025
April 1, 2025
1.6 years
April 25, 2024
April 9, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Adenoma detection rate
The numerator is the number of patients who had at least one adenoma on colonoscopy, and the denominator is the total number of patients who underwent colonoscopy
During Endoscopy procesure
Secondary Outcomes (5)
Polyp detection rate
During Endoscopy procesure
Detection rate of serrated adenoma
During Endoscopy procesure
Average number of polyps per colonoscopy
During Endoscopy procesure
Colonoscopy time
During Endoscopy procesure
Proportion of over-speed frames
During Endoscopy procesure
Study Arms (2)
AI-assisted group
Group with AI assistance
Control group
Group without AI assistance
Interventions
Polyps were identified by endoscopists assisted by an AI system: rectangular box marks; Monitoring of ileocecal position: whether blindness was reached was displayed in the lower left corner of the interface. Mirror entry and exit time monitoring: the operation time is displayed in the upper left corner of the interface. Colonoscopy withdrawal speed monitoring: the relative withdrawal speed was displayed on the left side of the interface.
Eligibility Criteria
patients required diagnostic colonoscopy, screening colonoscopy, or follow-up colonoscopy
You may qualify if:
- age \> 50 years old;
- required diagnostic colonoscopy, screening colonoscopy, or follow-up colonoscopy;
- voluntarily sign informed consent;
- Commitment to abide by the study procedures and cooperate with the implementation of the whole process of the study.
You may not qualify if:
- have participated in other clinical trials, signed informed consent and are in the follow-up period of other clinical trials;
- known polyposis syndrome patients;
- patients with known IBD;
- patients considered by the investigators to be unsuitable or unable to undergo complete digestive endoscopy and related examinations;
- high-risk diseases or other special conditions considered by the investigator to be unsuitable for clinical trial participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Renmin Hospital of Wuhan Univercity
Wuhan, Hubei, 430060, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2024
First Posted
May 9, 2024
Study Start
May 20, 2024
Primary Completion
December 30, 2025
Study Completion
December 30, 2025
Last Updated
April 13, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share